Network-based meta-analysis maps stage-dependent molecular programs in MASLD through MASLD-META NETWORK application
Metabolic dysfunction-associated steatotic liver disease (MASLD), the leading cause of chronic liver pathologies worldwide, represents a growing clinical burden. Its diagnosis remains reliant on liver biopsy that limits early detection and the ability to capture molecular changes across disease progression. A systemati...